» Articles » PMID: 22883350

Experimental Validation of Candidate Schizophrenia Gene ZNF804A As Target for Hsa-miR-137

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2012 Aug 14
PMID 22883350
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that mainly function as negative regulators of gene expression (Lai, 2002) and have been shown to be involved in schizophrenia etiology through genetic and expression studies (Burmistrova et al., 2007; Hansen et al., 2007a; Perkins et al., 2007; Beveridge et al., 2010; Kim et al., 2010). In a mega analysis of genome-wide association study (GWAS) of schizophrenia (SZ) and bipolar disorders (BP), a polymorphism (rs1625579) located in the primary transcript of a miRNA gene, hsa-miR-137, was reported to be strongly associated with SZ. Four SZ loci (CACNA1C, TCF4, CSMD1, C10orf26) achieving genome-wide significance in the same study were predicted and later experimentally validated (Kwon et al., 2011) as hsa-miR-137 targets. Here, using in silico, cellular and luciferase based approaches we also provide evidence that another well replicated candidate schizophrenia gene, ZNF804A, is also target for hsa-miR-137.

Citing Articles

Genetic Polymorphisms in miR-137 and Its Target Genes, TCF4 and CACNA1C, Contribute to the Risk of Bipolar Disorder: A Preliminary Case-Control Study and Bioinformatics Analysis.

Mokhtari M, Sargazi S, Saravani R, Heidari Nia M, Mirinejad S, Hadzsiev K Dis Markers. 2022; 2022:1886658.

PMID: 36193501 PMC: 9526595. DOI: 10.1155/2022/1886658.


Emerging Biosensors for Oral Cancer Detection and Diagnosis-A Review Unravelling Their Role in Past and Present Advancements in the Field of Early Diagnosis.

Umapathy V, Natarajan P, Swamikannu B, Moses J, Jones S, Chandran M Biosensors (Basel). 2022; 12(7).

PMID: 35884301 PMC: 9312890. DOI: 10.3390/bios12070498.


Consensus on potential biomarkers developed for use in clinical tests for schizophrenia.

Lin P, Sun J, Lou X, Li D, Shi Y, Li Z Gen Psychiatr. 2022; 35(1):e100685.

PMID: 35309241 PMC: 8867318. DOI: 10.1136/gpsych-2021-100685.


Malignancies and Biosensors: A Focus on Oral Cancer Detection through Salivary Biomarkers.

Goldoni R, Scolaro A, Boccalari E, Dolci C, Scarano A, Inchingolo F Biosensors (Basel). 2021; 11(10).

PMID: 34677352 PMC: 8533918. DOI: 10.3390/bios11100396.


A Review on the Expression Pattern of Non-coding RNAs in Patients With Schizophrenia: With a Special Focus on Peripheral Blood as a Source of Expression Analysis.

Ghafouri-Fard S, Eghtedarian R, Taheri M, Bruhl A, Sadeghi-Bahmani D, Brand S Front Psychiatry. 2021; 12:640463.

PMID: 34220567 PMC: 8249727. DOI: 10.3389/fpsyt.2021.640463.


References
1.
Hill M, Jeffries A, Dobson R, Price J, Bray N . Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion. Hum Mol Genet. 2011; 21(5):1018-24. DOI: 10.1093/hmg/ddr532. View

2.
Sullivan P, Kendler K, Neale M . Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003; 60(12):1187-92. DOI: 10.1001/archpsyc.60.12.1187. View

3.
Johnson M, Kawasawa Y, Mason C, Krsnik Z, Coppola G, Bogdanovic D . Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron. 2009; 62(4):494-509. PMC: 2739738. DOI: 10.1016/j.neuron.2009.03.027. View

4.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

5.
Xu B, Karayiorgou M, Gogos J . MicroRNAs in psychiatric and neurodevelopmental disorders. Brain Res. 2010; 1338:78-88. PMC: 2883644. DOI: 10.1016/j.brainres.2010.03.109. View